Latest Derivatives News

Page 38 of 44
LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.
Ada Torres
Ada Torres
29 Apr 2025
Far East Gold Ltd has advanced its exploration efforts in Indonesia with imminent drilling at Idenburg and Trenggalek, backed by a $4.78 million strategic investment from Xingye Gold, increasing their stake to nearly 20%.
Maxwell Dee
Maxwell Dee
29 Apr 2025
Canterbury Resources has reported significant advances at its Briggs Copper Project, including enhanced metallurgical recoveries and a resource upgrade, underpinning a scoping study on track for mid-2025 completion.
Maxwell Dee
Maxwell Dee
28 Apr 2025
Bendigo and Adelaide Bank clarifies a modest 5.8% variance in half-year cash earnings against market forecasts, confirming no material surprise and compliance with ASX disclosure rules.
Claire Turing
Claire Turing
18 Feb 2025
SEEK Limited's FY2025 half-year results reveal a 4% decline in sales revenue amid softer job ad volumes, yet the company impressively increased its interim dividend by 26%, supported by strong free cash flow growth.
Sophie Babbage
Sophie Babbage
18 Feb 2025
Asian Battery Metals PLC is set to launch its 2025 Phase 3 exploration program at the Oval Cu-Ni project in Mongolia, aiming to extend high-grade mineralisation and explore new geophysical targets with up to 1500 metres of diamond drilling.
Maxwell Dee
Maxwell Dee
18 Feb 2025
SRG Global has delivered a record first half in FY25, posting strong revenue and profit growth alongside a successful acquisition integration that boosts its water security and energy transition capabilities.
Victor Sage
Victor Sage
18 Feb 2025
ACDC Metals has completed a comprehensive metallurgical testwork program at its Goschen Central Project, confirming the viability of its processing flowsheet and advancing the project towards feasibility and potential offtake agreements.
Maxwell Dee
Maxwell Dee
17 Feb 2025
PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.
Ada Torres
Ada Torres
17 Feb 2025
Perpetual Resources has reported outstanding high-grade tin, tantalum, titanium, and niobium mineralisation from reconnaissance sampling at its Itinga Project in Brazil, revealing significant exploration upside in a historically underexplored region.
Maxwell Dee
Maxwell Dee
17 Feb 2025
Citigroup Global Markets Australia has announced a partially franked dividend of AUD 0.12 for the IAG CitiFirst Self-Funding Instalments, aligning key dates with IAG ordinary shares and reducing the outstanding loan balance.
Claire Turing
Claire Turing
17 Feb 2025
Citigroup Global Markets Australia has announced a fully franked AUD 0.30 dividend for its ORG CitiFirst Instalments, with key dates set for early March 2025.
Claire Turing
Claire Turing
14 Feb 2025